BISINTRA-DP Tablet
MRP: 2,151
Packaging: 10x10
Pack Type: tablet
Composition:
Bisoprolol Fumarate Ip.........5Mg Dapagliflozin Propanediol Monohydrate..........10Mg Excipient Q.S
Indication:
for the management of hypertension, angina, and chronic heart failure, helping to reduce cardiovascular mortality and hospitalizations.
Description:
This tablet combines Bisoprolol Fumarate, a cardioselective beta-blocker, and Dapagliflozin, a sodium-glucose co-transporter-2 (SGLT2) inhibitor. It is primarily used in patients with Type 2 Diabetes Mellitus and/or Heart Failure with Reduced Ejection Fraction (HFrEF). Bisoprolol helps reduce blood pressure and heart rate, while Dapagliflozin lowers blood glucose levels and improves cardiovascular outcomes.
Tags:
- Lowers blood pressure and heart rate
- Reduces risk of heart failure hospitalization
- Controls blood sugar in type 2 diabetes
- Promotes weight loss and reduces water retention
- Improves cardiovascular health
Usage Information
Dosage
Standard dose: One tablet daily (as per physician’s advice). Administration: Take with or without food, at the same time daily. Do not skip or double dose. Monitor blood sugar and blood pressure regularly.
Side Effects
Dizziness or fatigue Frequent urination Low blood pressure (hypotension) Hypoglycemia (if combined with insulin or sulfonylureas) Electrolyte imbalance Slow heartbeat (bradycardia)
Contraindications
Type 1 Diabetes Mellitus Severe renal impairment (eGFR <30 ml/min/1.73m²) Cardiogenic shock Hypotension or bradycardia Hypersensitivity to any ingredient Pregnancy and breastfeeding (consult physician)